DNAPrint Buys 18 Percent of Biofrontera for $1.8M, Expands Drug Pipeline | GenomeWeb

NEW YORK, July 14 (GenomeWeb News) - DNAPrint Genomics said yesterday that it had purchased an 18-percent share of Leverkusen, Germany-based Biofrontera for 1.5 million ($1.8 million), a prelude to t

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.